FOXO4–DRI Peptide — Senolytic Research Compound for Cellular Rejuvenation Science.

OXO4-DRI: The Senolytic Peptide Redefining Cellular Ageing Research.

In the rapidly advancing field of longevity and cellular biology, one compound has emerged as a truly landmark discovery: FOXO4-DRI. Designed to selectively eliminate senescent cells — the so-called “zombie cells” that accumulate with age and drive chronic inflammation, tissue dysfunction, and age-related disease — Buy FOXO4-DRI represents one of the most targeted and scientifically sophisticated senolytics available for research today.

For researchers, longevity scientists, and laboratory professionals seeking FOXO4 peptide for sale from a verified, high-purity supplier, CollagenPeptidesEU provides pharmaceutical-grade FOXO4-DRI with full third-party certification and fast European dispatch. If you’re ready to buy FOXO4-DRI for your research programme, this comprehensive guide covers the science, mechanism, clinical context, and everything else you need to know.

What Is FOXO4-DRI?

FOXO4-DRI is a D-retro-inverso (DRI) peptide — a modified, protease-resistant form of a sequence derived from the FOXO4 transcription factor protein. The compound was developed and validated by researchers at the Erasmus University Medical Center in the Netherlands, with pivotal findings published in the journal Cell in 2017.

Its design targets a specific protein-protein interaction that keeps senescent cells alive against their natural apoptotic cues. In healthy, functioning cells, the p53 tumour suppressor protein drives cell death when damage is detected. In senescent cells, FOXO4 pathologically sequesters p53 in the nucleus — essentially overriding the kill switch and allowing damaged, dysfunctional cells to persist indefinitely.

FOXO4-DRI is engineered to interrupt this interaction. By competitively binding to FOXO4 and displacing p53, it restores the apoptotic signal in senescent cells — triggering their elimination while leaving healthy cells unharmed. This exquisite selectivity is what makes FOXO4-DRI one of the most exciting and precise research tools in the ageing biology space, and why demand to buy FOXO4-DRI continues to grow among longevity researchers worldwide.

The Science Behind Senescent Cells

To fully appreciate why FOXO4 peptide research is generating such scientific excitement, it helps to understand what senescent cells are and why eliminating them matters.

Cellular senescence is a stress-response state in which damaged or dysfunctional cells permanently exit the cell cycle. While senescence serves a short-term protective role — preventing potentially cancerous cells from proliferating — the long-term accumulation of these cells is deeply problematic. Senescent cells secrete a cocktail of pro-inflammatory cytokines, proteases, and growth factors known collectively as the Senescence-Associated Secretory Phenotype (SASP).

SASP drives:

• Chronic low-grade inflammation (“inflammageing”) — a key driver of cardiovascular disease, neurodegeneration, and metabolic disorders
• Tissue degradation — via matrix metalloproteinase secretion that breaks down extracellular matrix integrity
• Paracrine senescence spread — where SASP factors induce senescence in neighbouring healthy cells
• Impaired regeneration — by suppressing stem cell function and tissue repair mechanisms

By eliminating senescent cells at their source, senolytics like FOXO4-DRI offer a mechanism-based approach to addressing these downstream consequences — making FOXO4 peptide for sale one of the most searched terms in contemporary longevity research.

Landmark Research: The 2017 Cell Paper

The scientific credibility behind FOXO4-DRI rests substantially on the 2017 Cell publication by Baar et al. — one of the most cited papers in ageing biology of the past decade. Key findings from this landmark study included:

• Selective apoptosis of senescent cells — FOXO4-DRI triggered programmed cell death specifically in senescent cells, with minimal impact on healthy proliferating or quiescent cells
• Hair regrowth in chemotherapy models — mice with chemo-induced alopecia showed significant hair regrowth following FOXO4-DRI treatment, indicating reversal of therapy-induced senescence
• Improved physical fitness and renal function — naturally aged mice treated with FOXO4-DRI demonstrated measurable improvements in running speed, grip strength, and kidney health markers
• Reduced liver damage in NAFLD models — senescent cell clearance correlated with hepatic inflammation reduction in metabolic disease mouse models

These findings established FOXO4-DRI not merely as a promising compound, but as a validated proof-of-concept for targeted senolysis — driving sustained interest from researchers seeking FOXO4 peptide for sale backed by rigorous scientific pedigree.

FOXO4-DRI in the Context of Longevity Research

FOXO4-DRI sits at the intersection of several of the most active areas in modern biomedical research: senolytics, p53 biology, proteostasis, and the emerging longevity therapeutics space. It is frequently discussed alongside other senolytics such as Dasatinib + Quercetin (D+Q) and Navitoclax (ABT-263), and represents the only peptide-based approach among the leading senolytic candidates.

Its peptide format confers several research advantages:

• High selectivity — targets a specific protein-protein interaction rather than broad apoptotic pathways
• Tuneable dosing — amenable to precise concentration-response studies in both in vitro and in vivo settings
• DRI modification — the D-retro-inverso format significantly enhances resistance to proteolytic degradation, extending functional half-life in biological environments
• Non-genotoxic mechanism — unlike some small-molecule senolytics, FOXO4-DRI does not directly damage DNA to induce apoptosis

For longevity-focused research institutions and pharmaceutical pre-clinical teams, the decision to buy FOXO4-DRI from a purity-verified source is therefore a foundational investment in high-quality experimental output.

Why Choose CollagenPeptidesEU for FOXO4-DRI?

When looking for FOXO4 peptide for sale from a supplier that matches your research standards, CollagenPeptidesEU delivers across every critical dimension:

• ✅ ≥98% purity — verified by independent HPLC and mass spectrometry with full batch traceability
• ✅ Certificate of Analysis (CoA) available with every order — complete transparency before and after purchase
• ✅ DRI-modified format — confirmed protease-resistant D-retro-inverso configuration for extended research stability
• ✅ Lyophilised powder — optimal shelf stability; reconstitute only what you need
• ✅ Fast EU-based dispatch — temperature-controlled, discreet packaging as standard
• ✅ Knowledgeable support team — familiar with senolytic research protocols and FOXO4-DRI handling requirements
• ✅ Transparent, competitive pricing — no surprises at checkout

Whether this is your first time searching for FOXO4 peptide for sale or you’re re-ordering for an ongoing programme, CollagenPeptidesEU is the trusted EU source for serious researchers.

Product Specifications: FOXO4-DRI Peptide

Frequently Asked Questions

Where can I find FOXO4 peptide for sale with documented purity? CollagenPeptidesEU offers FOXO4 peptide for sale with independently verified ≥98% purity. Every vial is accompanied by a full Certificate of Analysis, available on request prior to purchase.

What does “DRI” mean in FOXO4-DRI? DRI stands for D-Retro-Inverso — a peptide chemistry modification in which the amino acid sequence is both reversed and composed of D-amino acids (mirror images of natural L-amino acids). This modification makes the peptide highly resistant to proteolytic degradation, substantially extending its functional stability in biological environments.

Is FOXO4-DRI safe for human use? FOXO4-DRI is currently an investigational research compound with no approved human therapeutic applications. It is available exclusively for in vitro and pre-clinical laboratory research. Always consult your institutional ethics board and regulatory framework before use.

How does FOXO4-DRI differ from other senolytics like Dasatinib + Quercetin? Unlike D+Q, which target broad survival pathways (BCL-2 family proteins and tyrosine kinases), FOXO4-DRI acts with exquisite precision on a single protein-protein interaction — the FOXO4/p53 axis specifically activated in senescent cells. This selectivity reduces off-target risk and makes it a uniquely clean tool for mechanistic senolysis research.

How should I reconstitute FOXO4-DRI for research use? FOXO4-DRI is typically reconstituted in sterile water or DMSO at research-grade concentrations. Specific reconstitution guidance is provided with every order from CollagenPeptidesEU, alongside the CoA documentation.

Conclusion

FOXO4-DRI stands as one of the most scientifically validated, mechanistically precise, and conceptually exciting research peptides in the longevity and cellular ageing field. From its landmark Cell publication and selective p53-restoring mechanism, to its unique DRI modification and growing prominence in global longevity research programmes — every dimension of this compound signals exceptional scientific value.

For researchers ready to buy FOXO4-DRI or locate trusted FOXO4 peptide for sale from a supplier that takes quality as seriously as you do, CollagenPeptidesEU is your authoritative European research partner. Browse our full senolytic and longevity peptide catalogue, download your CoA, and place your order with complete confidence today.

Disclaimer: FOXO4-DRI is sold exclusively for in vitro and laboratory research purposes. It is not approved for human consumption, self-administration, or therapeutic use. All research must be conducted in compliance with applicable institutional and jurisdictional regulations governing the use of investigational peptide compounds.